Viagra, the anti-impotence drug, was declared safe for sale in the European
Union this week by the European Agency for the Evaluation of Medicinal Products.
Britain’s health secretary, Frank Dobson, says that for the time being the
National ÎçÒ¹¸£Àû1000¼¯ºÏ Service will not pay for it, although Pfizer, the drug’s
manufacturer, says the company has already agreed prices with the NHS. Dobson
promises a definitive ruling in the next few weeks. Other European health
systems are still discussing with Pfizer how much they will pay for the drug.
Viagra will require a prescription across the EU.
More from New Scientist
Explore the latest news, articles and features
Physics
Gravity's strength measured more reliably than ever before
News
Mind
Symptoms of early dementia reversed by bespoke treatment plans
News
Physics
QBox theory may offer glimpse of reality deeper than quantum realm
News
ÎçÒ¹¸£Àû1000¼¯ºÏ
Is stem cell therapy about to transform medicine and reverse ageing?
Comment
Popular articles
Trending New Scientist articles
1
Can you slow ageing with your diet? A new book gives it a go
2
Symptoms of early dementia reversed by bespoke treatment plans
3
QBox theory may offer glimpse of reality deeper than quantum realm
4
Largest-ever octopus was great white shark of invertebrate predators
5
Why your opinion of used electric vehicles is probably wrong
6
How autoimmune conditions can unexpectedly drive mental illness
7
Gravity's strength measured more reliably than ever before
8
Surprising male G-spot found in most detailed study of the penis yet
9
Why the right kind of stress is crucial for your health and happiness
10
The monstrous number sequences that break the rules of mathematics
